individuals age 18-50
Showing 1 - 25 of >10,000
Dengue Trial (V181, Butantan-DV)
Not yet recruiting
- Dengue
- V181
- Butantan-DV
- (no location specified)
Jan 24, 2023
Traumatic Brain Injury, Cerebral Edema Trial (ABX-101 1mg, ABX-101 2mg)
Not yet recruiting
- Traumatic Brain Injury
- Cerebral Edema
- ABX-101 1mg
- ABX-101 2mg
- (no location specified)
Oct 20, 2023
Sexually Transmitted Diseases Trial in Lenexa (NgG low dose investigational vaccine, NgG medium dose investigational vaccine,
Recruiting
- Sexually Transmitted Diseases
- NgG low dose investigational vaccine
- +5 more
-
Lenexa, KansasGSK Investigational Site
Jan 6, 2023
Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)
Recruiting
- Thyroid Eye Disease
- TOUR006 - 20 MG
- +2 more
-
Miami, FloridaSite - 0103
Oct 11, 2023
Virus Diseases Trial in Rochester (1 µg CoV2 SAM (LNP))
Completed
- Virus Diseases
- 1 µg CoV2 SAM (LNP)
-
Rochester, New YorkGSK Investigational Site
May 16, 2022
COVID-19 Trial in United States (NVX-CoV2373, SARS-CoV-2 rS antigen/Matrix-M Adjuvant)
Active, not recruiting
- COVID-19
- NVX-CoV2373
- SARS-CoV-2 rS antigen/Matrix-M Adjuvant
-
Austin, Texas
- +4 more
May 16, 2023
Typhoid Fever Trial (TYP04A Low Dose without adjuvant investigational vaccine, TYP04B Full Dose without adjuvant investigational
Not yet recruiting
- Typhoid Fever
- TYP04A Low Dose without adjuvant investigational vaccine
- +5 more
- (no location specified)
Nov 4, 2022
Respiratory Syncytial Virus Infection Trial in Puerto Rico, United States (RSV mRNA LNP CL-0059 Low dose, RSV mRNA LNP CL-0137
Recruiting
- Respiratory Syncytial Virus Infection
- RSV mRNA LNP CL-0059 Low dose
- +6 more
-
Hollywood, Florida
- +4 more
Jan 17, 2023
Being in the 18-50 Age Population, Being Diagnosed With Frozen Shoulder by a Specialist Physician, Volunteer to Participate in
Recruiting
- Being in the 18-50 Age Population
- +2 more
- vagus nerve stimulation
-
Malatya, Battalgazi̇, TurkeyMalatya Sevgi Hospital
Oct 17, 2022
Healthy Volunteers Trial in United Kingdom (mRNA-1769, Placebo)
Recruiting
- Healthy Volunteers
- mRNA-1769
- Placebo
-
Bradford, United Kingdom
- +11 more
Aug 18, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Moderate to Severe Chronic Plaque-type Psoriasis Trial in Worldwide (secukinumab low dose, secukinumab high dose)
Active, not recruiting
- Moderate to Severe Chronic Plaque-type Psoriasis
- secukinumab low dose
- secukinumab high dose
-
Fountain Valley, California
- +22 more
Dec 24, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- BNT162b2.B.1.351
-
Oakland, California
- +16 more
Feb 17, 2022
Ebola Trial in Brisbane, Melbourne, Nedlands (Base Dose EBOV GP Vaccine, 2x Base Dose EBOV GP Vaccine, 4x Base Dose EBOV GP
Completed
- Ebola
- Base Dose EBOV GP Vaccine
- +5 more
-
Brisbane, Queensland, Australia
- +2 more
Nov 23, 2021
Vaccine for Meningococcal Disease Trial in India (NmCV-5, Menactra)
Completed
- Vaccine for Meningococcal Disease
- NmCV-5
- Menactra
-
New Delhi, Delhi, India
- +10 more
Sep 4, 2021
Study of Vitamin D Fortification of Milk and Oil
Active, not recruiting
- Healthy Individuals
-
Pune, Maharashtra, IndiaHirabai Cowasji Jehangir Medical Research Institute
Sep 12, 2022
Database of Positon Emission Tomography Digital Brain Exams, in
Completed
- Neurodegenerative Diseases
- 18F FDG PET exam
-
Vandoeuvre-les-Nancy Cedex, FranceUniversity hospital of Nancy
Nov 25, 2020
Pneumococcal Disease Trial in Worldwide (V116, PPSV23)
Recruiting
- Pneumococcal Disease
- V116
- PPSV23
-
Blacktown, New South Wales, Australia
- +50 more
Jan 25, 2023
Cytomegalovirus (CMV) Infection Trial in Worldwide (Letermovir oral granules, Letermovir tablet, Letermovir intravenous)
Active, not recruiting
- Cytomegalovirus (CMV) Infection
- Letermovir oral granules
- +2 more
-
Duarte, California
- +39 more
Jan 9, 2023
Tick-borne Encephalitis, Vaccine Trial in Örebro (FSME-IMMUN Vaccine)
Not yet recruiting
- Tick-borne Encephalitis
- Vaccine
- FSME-IMMUN Vaccine
-
Örebro, SwedenRegion Örebro Län
Apr 26, 2022
COVID-19 Trial in Rio De Janeiro (Adsorbed COVID-19 (inactivated) Vaccine)
Active, not recruiting
- COVID-19
- Adsorbed COVID-19 (inactivated) Vaccine
-
Rio De Janeiro, Brazil
- +1 more
Jul 6, 2021
Cognitive Functions After COVID-19
Completed
- COVID-19 Acute Respiratory Distress Syndrome
- Cognitive Decline
- Neuropsychometric Test
-
Beykoz, İstanbul, TurkeyIstanbul Medipol University
Aug 3, 2022
Respiratory Syncytial Virus Infections Trial in Santiago (rBCG-N-hRSV 1/100, rBCG-N-hRSV 1/10, rBCG-N-hRSV full dose)
Completed
- Respiratory Syncytial Virus Infections
- rBCG-N-hRSV 1/100
- +3 more
-
Santiago, ChilePontificia Universidad Católica de Chile
Nov 18, 2020
Longterm Outcomes of Individuals With Anorectal Malformations
Recruiting
- Anorectal Malformations
-
Stockholm, SwedenKarolinska University Hospital
Mar 29, 2022